| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President and CEO
1 company
Christopher Richard Anzalone is Chief Executive Officer at ARWR. From March 2015 to January 2026, the filings on record show 0 open-market purchases and 37 sales. Christopher Richard Anzalone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $225.8M at current prices.
Historically, Christopher Richard Anzalone's trades have earned a middling insider score of 60/100 across 27 rated trades. Over a 12-month horizon, 55.0% of those trades were profitable, with an average 12-month return of -24.1%.
The ARWR filings lean toward selling, a net 3,054,419 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell10b5-1 | 26,712 | $21.24 | $567,485.84 | -0.7% | -25.9% | +226.5% | |
| Jan 31, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 57,499 | $32.35 | $1,860,019.34 | -1.5% | -29.5% | -37.0% | |
| Jan 2, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell10b5-1 | 9,952 | $31.01 | $308,636.66 | -0.3% | -8.9% | -36.6% | |
| Dec 20, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell10b5-1 | 12,000 | $28.54 | $342,480.00 | -0.3% | -0.2% | -29.9% | |
| Oct 25, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell10b5-1 | 24,338 | $24.21 | $589,222.98 | -0.6% | +43.0% | -16.9% | |
| Sep 18, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 57,755 | $28.12 | $1,624,222.64 | -1.5% | -0.7% | -28.9% | |
| May 4, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 104,928 | $39.32 | $4,125,673.52 | -2.7% | -17.7% | -39.0% | |
| Feb 11, 2022 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 146,388 | $51.91 | $7,598,864.47 | -3.5% | -40.2% | -34.6% | |
| Dec 15, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 60,000 | $67.56 | $4,053,431.46 | -1.8% | -42.1% | -55.3% | |
| Oct 22, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 65,000 | $65.77 | $4,274,981.60 | -1.9% | -20.5% | -49.4% |